close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
News headline image
More Than 1 Million Suicidal Depression Cases Per Year May Be Treated by 2030 via New Indication for Augmentation of Transcranial Magnetic Stimulation: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
News headline image
From Shrimp To Shredded Cheese, America’s Packaged Food Recall Is Getting A Bit Chaotic — And Testing Shoppers’ Nerves ↗
Via Stocktwits
Topics Death Product Recall
Tickers COST KR PBJ SPY WMT
Exposures Death Legal Product Safety
News headline image
Is DexCom Stock Underperforming the S&P 500?
Via Barchart.com
Topics Economy Stocks World Trade
Exposures Product Safety Supply Chain Tariff
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? ↗
Via The Motley Fool
Tickers PGEN
Exposures Product Safety
News headline image
Prediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026 ↗
Via The Motley Fool
Topics Earnings
Tickers MIRM
Exposures Financial Product Safety
News headline image
Rivian To Recall 34,824 Vehicles After Seatbelt Failure Warning ↗
Via Benzinga
Topics Product Recall
Tickers RIVN
Exposures Legal Product Safety
News headline image
Don't Buy Summit Therapeutics Until This Big Thing Happen ↗
Via The Motley Fool
Tickers SMMT
Exposures Product Safety
News headline image
Rising Patient Interest in ‘Spravato Near Me’ Highlights Demand for Advanced Depression Treatment in Gilbert
Via AB Newswire
Exposures Product Safety
News headline image
CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
News headline image
Why Vera Therapeutics Stock Rocked the Market on Tuesday ↗
Via The Motley Fool
Tickers RJF VERA
Exposures Product Safety
News headline image
FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
Via PRLog
Exposures Product Safety
News headline image
Coach Todd Campbell Calls for Stronger Veteran Support: “We Can All Show Up”
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
AI-Assisted Ultrasounds Mark a New Era in Detecting Congenital Heart Defects
Via TokenRing AI
Topics Artificial Intelligence
Tickers GOOGL MSFT NVDA
Exposures Artificial Intelligence Product Safety
News headline image
FDA Takes Bold Leap into Agentic AI, Revolutionizing Healthcare Regulation
Via TokenRing AI
Topics Artificial Intelligence
Tickers AMZN GOOGL MSFT
Exposures Artificial Intelligence Product Safety
News headline image
CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
Via PRLog
Exposures Product Safety
News headline image
Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety
Via PRLog
Exposures Product Safety
News headline image
FDA Submission for Abbreviated New Drug Application; $750 Million Market for Suicidal Depression Market Awaits Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
News headline image
Beyond the Headlines: Understanding the Forces Driving Today's Stock Market
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
Tickers AMZN GOOGL MSFT NVDA TGT WMT
Exposures Artificial Intelligence Climate Economy
News headline image
United Natural Foods (UNFI) Beats Earnings Estimates, Signaling Resilience in Supermarket Sector
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Tickers AMZN CORE KR NGVC SFM SPTN
Exposures Artificial Intelligence Financial Interest Rates
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
News headline image
Envoy Medical Announces the Grant of Its 40th U.S. Patent
Via Newsfile
Topics Intellectual Property
Tickers ASX:COH COCH
Exposures Intellectual Property Product Safety
News headline image
Stock Index Futures Gain as Investors Recover Risk Appetite
Via Barchart.com
Topics Death Economy Stocks
Tickers COIN GS NVDA UBS
Exposures COVID-19 Death Economy
News headline image
CCHR: Millions of U.S. Children Funneled into Dangerous Drug Polypharmacy
Via Send2Press
Exposures Product Safety
News headline image
Here's Why Grail Soared, Again, in November ↗
Via The Motley Fool
Tickers ABT EXAS GRAL
Exposures Product Safety
News headline image
As Boeing Rival Airbus Faces Fresh Issue With Fuselage, Here Are Airlines With Largest A320 Fleets In US ↗
Via Benzinga
Topics Product Recall Supply Chain
Tickers BA
Exposures Legal Product Safety Supply Chain
News headline image
Dave Ramsey Recalls When He Was Poor &amp; His Car Broke Down On Third Date: &#39;I Had $1.16 In My Account&#39; And Was Telling Her &#39;I&#39;m Gonna Be A Millionaire&#39; ↗
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
News headline image
Patients Deserve Safe, FDA-Approved Obesity Treatments—Not Risky Knockoffs
Via NewsUSA
Topics Government
Exposures Political Product Safety
News headline image
Qure Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
Via NewMediaWire
Topics Fraud
Tickers QURE
Exposures Legal Product Safety
News headline image
Qure Investigation Notification: Kessler Topaz Meltzer &amp; Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud
Tickers QURE
Exposures Legal Product Safety
News headline image
AHA Urges FDA for Balanced AI Regulation in Healthcare: Prioritizing Safety and Innovation
Via TokenRing AI
Topics Artificial Intelligence Product Recall
Tickers GOOGL IBM MSFT
Exposures Artificial Intelligence Legal Product Safety
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today